Live from the NIH registry
Studies recruiting near Tampa right now
Top 25 of 1,316 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Joseph's Hospital/Children's Hospital-Tampa — Tampa, Florida (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University of Florida — Tampa, Florida (3.4 mi)
· Sponsor: Westat
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
USF Diabetes and Endocrinology Center — Tampa, Florida (3.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Comprehensive Hematology Oncology — St. Petersburg, Florida (21.1 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Erasca, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Vitreous Associates of Florida — St. Petersburg, Florida (21.1 mi)
· Sponsor: Genentech, Inc.
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida (21.1 mi)
· Sponsor: Takeda
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Santos Research Center, Corp - Tampa — Tampa, Florida (3.4 mi)
· Sponsor: AbbVie
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Florida Cancer Specialists - North — St. Petersburg, Florida (21.1 mi)
· Sponsor: Mirati Therapeutics Inc.
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
Unresectable Metastatic Colorectal Cancer
Phase 1
Interventional 49 participants sought
Moffit Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Celyad Oncology SA
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Moffitt Cancer Center-International Plaza — Tampa, Florida (3.4 mi)
· Sponsor: SWOG Cancer Research Network
Lay-Delivered Behavioral Activation in Senior Centers
Depression
N/A
Interventional 288 participants sought
JL Young Apartments (Senior Housing) — Tampa, Florida (3.4 mi)
· Sponsor: University of Washington
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Alliance Clinical Research of Tampa, LLC — Tampa, Florida (3.4 mi)
· Sponsor: Takeda
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Optimum Clinical Trial Group — Tampa, Florida (3.4 mi)
· Sponsor: Philip Morris Products S.A.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Brandon, Florida (10.5 mi)
· Sponsor: Alkermes, Inc.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Advanced Liver Cancer
Phase 1
Interventional 200 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Abbisko Therapeutics Co, Ltd
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
GCP Clinical Research- Site Number : 8400016 — Tampa, Florida (3.4 mi)
· Sponsor: Sanofi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Tampa Cardiovascular Interventions and Research — Tampa, Florida (3.4 mi)
· Sponsor: Duke University
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Tampa, Florida (3.4 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung Disease, Common Variable Immunodeficiency
Phase 2
Interventional 38 participants sought
University of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Advanced Urology Institute, LLC — Largo, Florida (21.8 mi)
· Sponsor: Pfizer
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 1
Interventional 145 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Kestrel Therapeutics, Inc.
IM ABLE 2: Injuries Managed With Advanced Bracing for Lower Extremities
Lower Limb Injury, Ankle Foot Orthosis (AFO)
N/A
Interventional 75 participants sought
University of South Florida, Rehabilitation Robotics & Prosthetics Testbed (RRT) — Tampa, Florida (3.4 mi)
· Sponsor: University of South Florida